Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Been out a while. Has Myrbetriq hit the number #1 prescribed OAB agent? Or Has the fact Vesicare is going generic stopped that? What about the fact a combo drug with those two will have crap coverage? How are the feeling of the sales force?